RxSight, Inc. Operating Income
RxSight, Inc. (RXST) reported Operating Income of -$13.77 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-05
- RxSight, Inc. operating income (loss) for the quarter ending 2026-06-30 was -$13.77M.
- RxSight, Inc. operating income (loss) for the quarter ending 2026-03-31 was -$17.83M.
- RxSight, Inc. operating income (loss) for the quarter ending 2025-12-31 was -$11.34M.
- RxSight, Inc. operating income (loss) for the quarter ending 2025-09-30 was -$12.18M.
- RxSight, Inc. operating income (loss) for fiscal 2025 was -$48.19M.
- RxSight, Inc. operating income (loss) for fiscal 2024 was -$36.86M.
- RxSight, Inc. operating income (loss) for fiscal 2023 was -$50.09M.
- RxSight, Inc. operating income (loss) for fiscal 2022 was -$63.32M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$13.77M 10-Q · filed 2026-08-05 | -$31.60M 10-Q · filed 2026-08-05 | -$42.94M derived: sum of 3 quarters · filed 2026-08-05 | -$55.11M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$17.83M 10-Q · filed 2026-05-06 | -$29.17M derived: sum of 2 quarters · filed 2026-05-06 | -$41.34M derived: sum of 3 quarters · filed 2026-05-06 | -$55.35M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$11.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$23.52M derived: sum of 2 quarters · filed 2026-02-25 | -$37.52M derived: sum of 3 quarters · filed 2026-08-05 | -$48.19M 10-K · filed 2026-02-25 |
| 2025-09-30 | -$12.18M 10-Q · filed 2025-11-05 | -$26.18M derived: sum of 2 quarters · filed 2026-08-05 | -$36.85M 10-Q · filed 2025-11-05 | -$45.48M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$14.00M 10-Q · filed 2026-08-05 | -$24.68M 10-Q · filed 2026-08-05 | -$33.30M derived: sum of 3 quarters · filed 2026-08-05 | -$42.53M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$10.67M 10-Q · filed 2026-05-06 | -$19.30M derived: sum of 2 quarters · filed 2026-05-06 | -$28.53M derived: sum of 3 quarters · filed 2026-05-06 | -$36.86M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$8.63M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$17.85M derived: sum of 2 quarters · filed 2026-02-25 | -$26.19M derived: sum of 3 quarters · filed 2026-02-25 | -$36.86M 10-K · filed 2026-02-25 |
| 2024-09-30 | -$9.23M 10-Q · filed 2025-11-05 | -$17.56M derived: sum of 2 quarters · filed 2025-11-05 | -$28.23M 10-Q · filed 2025-11-05 | -$39.08M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | -$8.33M 10-Q · filed 2025-08-07 | -$19.00M 10-Q · filed 2025-08-07 | -$29.86M derived: sum of 3 quarters · filed 2026-02-25 | -$42.37M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | -$10.67M 10-Q · filed 2025-05-07 | -$21.52M derived: sum of 2 quarters · filed 2026-02-25 | -$34.03M derived: sum of 3 quarters · filed 2026-02-25 | -$47.66M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | -$10.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$23.36M derived: sum of 2 quarters · filed 2026-02-25 | -$36.99M derived: sum of 3 quarters · filed 2026-02-25 | -$50.09M 10-K · filed 2026-02-25 |
| 2023-09-30 | -$12.51M 10-Q · filed 2024-11-07 | -$26.14M derived: sum of 2 quarters · filed 2024-11-07 | -$39.23M 10-Q · filed 2024-11-07 | -$54.22M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | -$13.63M 10-Q · filed 2024-08-05 | -$26.72M 10-Q · filed 2024-08-05 | -$41.71M derived: sum of 3 quarters · filed 2025-02-25 | -$57.67M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | -$13.10M 10-Q · filed 2024-05-06 | -$28.09M derived: sum of 2 quarters · filed 2025-02-25 | -$44.05M derived: sum of 3 quarters · filed 2025-02-25 | -$59.84M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | -$14.99M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$30.95M derived: sum of 2 quarters · filed 2025-02-25 | -$46.74M derived: sum of 3 quarters · filed 2025-02-25 | -$63.32M 10-K · filed 2025-02-25 |
| 2022-09-30 | -$15.96M 10-Q · filed 2023-11-09 | -$31.75M derived: sum of 2 quarters · filed 2023-11-09 | -$48.33M 10-Q · filed 2023-11-09 | -$62.99M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$15.79M 10-Q · filed 2023-08-07 | -$32.37M 10-Q · filed 2023-08-07 | -$47.03M derived: sum of 3 quarters · filed 2023-08-07 | -$60.15M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | -$16.58M 10-Q · filed 2023-05-09 | -$31.24M derived: sum of 2 quarters · filed 2023-05-09 | -$44.35M derived: sum of 3 quarters · filed 2023-05-09 | -$58.23M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | -$14.66M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | -$27.77M derived: sum of 2 quarters · filed 2023-03-06 | -$41.65M derived: sum of 3 quarters · filed 2023-03-06 | -$52.79M 10-K · filed 2023-03-06 |
| 2021-09-30 | -$13.11M 10-Q · filed 2022-11-07 | -$26.99M derived: sum of 2 quarters · filed 2022-11-07 | -$38.12M 10-Q · filed 2022-11-07 | -$46.43M derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-06-30 | -$13.88M 10-Q · filed 2022-08-08 | -$25.01M 10-Q · filed 2022-08-08 | -$33.31M derived: sum of 3 quarters · filed 2022-08-08 | -$42.22M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | -$11.13M 10-Q · filed 2022-05-05 | -$19.44M derived: sum of 2 quarters · filed 2022-05-05 | -$28.34M derived: sum of 3 quarters · filed 2022-05-05 | -$37.15M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | -$8.30M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | -$17.21M derived: sum of 2 quarters · filed 2022-03-08 | -$26.02M derived: sum of 3 quarters · filed 2022-03-08 | -$35.41M 10-K · filed 2022-03-08 |
| 2020-09-30 | -$8.91M 10-Q · filed 2021-11-10 | -$17.71M derived: sum of 2 quarters · filed 2021-11-10 | -$27.11M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | -$8.81M 10-Q · filed 2021-09-09 | -$18.20M 10-Q · filed 2021-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |